GlassScriptPhysician profile
Archibold Melcher
NPI 1346777448
$4,191.69
in general payments reported to CMS, 2019-2025
11 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what 97% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.05 · 2021: $428 · 2022: $127 · 2023: $143 · 2024: $2,138 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,357 · Food and Beverage: $1,041 · Gift: $936 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,356.93 |
| Food and Beverage | $1,040.86 |
| Gift | $936.44 |
| Education | $263.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,319.85 | 2022-2025 | |
| Ultradent Products INC | $945.93 | 2024-2025 | Opalescence |
| Zimmer Biomet Holdings, INC. | $350.00 | 2021 | |
| Hu-Friedy Mfg. Co., LLC | $263.35 | 2025 | Hu-Friedy |
| Biohorizons Implant Systems INC. | $82.95 | 2022 | |
| Align Technology, INC. | $64.16 | 2020-2021 | |
| Dentsply Sirona INC | $49.23 | 2020-2024 | Cavitron |
| Ucb, INC. | $42.79 | 2020-2025 | Fintepla |
| Alexion Pharmaceuticals, INC. | $39.01 | 2025 | Ultomiris |
| Impel Pharmaceuticals INC. | $17.94 | 2023 | Trudhesa |
| Philips North America LLC | $16.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archibold Melcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.